Correlation Between C4 Therapeutics and Edgewise Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on C4 Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Edgewise Therapeutics.

Diversification Opportunities for C4 Therapeutics and Edgewise Therapeutics

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between CCCC and Edgewise is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Edgewise Therapeutics go up and down completely randomly.

Pair Corralation between C4 Therapeutics and Edgewise Therapeutics

Given the investment horizon of 90 days C4 Therapeutics is expected to generate 1.22 times more return on investment than Edgewise Therapeutics. However, C4 Therapeutics is 1.22 times more volatile than Edgewise Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.2 per unit of risk. If you would invest  385.00  in C4 Therapeutics on October 20, 2024 and sell it today you would earn a total of  9.00  from holding C4 Therapeutics or generate 2.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

C4 Therapeutics  vs.  Edgewise Therapeutics

 Performance 
       Timeline  
C4 Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Edgewise Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Edgewise Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

C4 Therapeutics and Edgewise Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with C4 Therapeutics and Edgewise Therapeutics

The main advantage of trading using opposite C4 Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.
The idea behind C4 Therapeutics and Edgewise Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance